Skip to content
Keeping Current CME cover art

All Episodes

Keeping Current CME — 785 episodes · page 4 of 8

#
Title
301

Life With Cardiac Amyloidosis

302

Quiz Time! Test Your Knowledge on Treatments for Gastroesophageal Reflux Disease

303

What's New in the Treatment of Gastroesophageal Reflux Disease and Erosive Esophagitis: Spring Meeting Updates

304

EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies

305

There Are Multiple Ways to Treat R/R CLL or R/R MCL: What Would the Experts Do?

306

Multiple Sclerosis Biosimilars in the United States: How to Communicate With Your Patient for Successful Implementation

307

To Switch or Not to Switch: Patient Case Discussions on Integrating Biosimilars in Multiple Sclerosis Care

308

Enhancing Equitable HIV Care With Long-Acting Injectable Antiretrovirals: Why It Matters

309

International Expert Recommendations for Timely and Accurate Diagnosis of Alzheimer's Disease in Primary Care

310

Case Study in Managing in MASLD/MASH

311

Renal Denervation for High Blood Pressure: Long-Term Control or Short-Term Bandage?

312

Cardiac Implantable Electronic Device (CIED) Infections: How Well Are Patients Really Doing? Real-Time Gaps and Implications for Evidence-Based Care

313

Beyond Positive Symptoms in Schizophrenia: What Else Should We Be Actively Looking Out For?

314

Improving Outcomes in Schizophrenia in Underserved Communities

315

Hepatitis C Screening and Beyond: Role of the Primary Care Team in Addressing Inequities

316

Evolution of the Care of Patients With Advanced Ovarian Cancer

317

Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In?

318

Knowing How and When to Switch Medications in Schizophrenia

319

For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

320

Care Pathways for Diagnostic Excellence: Understanding Provider Roles and Responsibilities

321

Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

322

Insights From the Experts on Prescription Digital Therapeutics in Psychiatry

323

Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors

324

Expert Analysis of Hereditary Angioedema Data: Unlocking Practice Implications From AAAAI

325

Obesity in Childhood and Adolescence: The Pediatrician in Charge?

326

Identify and Act, Part 2: What's New in Managing Homozygous Familial Hypercholesterolemia?

327

Navigating the Management of Epidermolysis Bullosa: A Case-Based Discussion on How to Integrate Novel Therapies Into Clinical Practice

328

Primary Biliary Cholangitis: Targeting New Treatment Goals

329

Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer

330

What You Always Wanted to Know About Obesity but Never Dared to Ask: Quick Questions and Rapid Replies

331

Selecting Therapies to Optimize Treatment Success in Schizophrenia

332

Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations

333

Which Endpoints Matter Most in Transthyretin Amyloid Cardiomyopathy Trials? Are We Comparing Apples to Apples?

334

Current Unmet Needs in Schizophrenia: Assessing Gaps in Care

335

Cognitive Impairment and Negative Symptoms in Schizophrenia: Recognizing Hidden Disabilities

336

Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?

337

OncoChallenge in Locally Advanced Head and Neck Cancer: Exploring New Directions

338

Updates on Cardiac Implantable Electronic Device Infections: New Data Driving the Need to Treat and Beat Infection

339

6 Practical Steps to Integrating Long-Acting Injectables for HIV Prevention and Treatment

340

Advances in Topical Treatments for Seborrheic Dermatitis

341

Clinical Debates in Psoriatic Arthritis: Is a JAK Inhibitor Right for This Patient?

342

Evolving Landscape of HR-Positive Metastatic Breast Cancer: A Year in Review

343

The Science of Janus Kinase Inhibitors Across Immunologic Diseases

344

Relapsed/Refractory Multiple Myeloma: A Case-Based Tumor Board

345

Cardiac Amyloidosis: The Red Flags to Consider

346

The Expanding Role of Mutation Testing in Advanced Gastrointestinal Stromal Tumor: From Biology to Therapy Rationale

347

How to Prepare Yourself and Your Practice for Adults With Rare Pediatric-Onset Epilepsies

348

Applying the Evidence: Newer Therapies for Dravet Syndrome and Lennox-Gastaut Syndrome

349

Updates in Breast Cancer From San Antonio 2023: Practice-Changing Data and Clinical Implications

350

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?

351

Multidisciplinary Team Best Practices to Improve Adherence for High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Cases From the Community

352

The Age of Respiratory Syncytial Virus Prevention: Empowering Pharmacists to Optimize Disease Protection in Older Adults

353

Essential Facts About Obesity: Effective and Appropriate Use of Novel Weight-Loss Medications

354

Confronting Obesity in Cardiology Care: A Major Driver of Cardiovascular Risk

355

Why Do I Need Adjuvant Therapy? Communicating the Risks for HR-Positive, HER2-Negative EBC at High Risk of Recurrence

356

Understanding the Concerns and Challenges of Patients With HR-Positive/HER2-Negative EBC: Expert Insights and Recommendations

357

Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

358

Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice

359

From Symptom to Solution: Best Practices in Syndromic Testing for Improved Patient Outcomes

360

Novel Biologic Therapies for Spondyloarthritis: The Year in Review

361

Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors

362

Personalizing Risk Assessment to Enhance Primary Cardiovascular Prevention: From Methods to Interpretation

363

Nonalcoholic Steatohepatitis: Mission Possible!

364

Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung Cancer

365

ROS1-Positive Advanced NSCLC: Sharing Best Practice From the Clinic to Maximize Patient Outcomes

366

What Does It All Mean for Your Practice? Closing Remarks From the Conference Chairs

367

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist

368

Exploring New Strategies for the Management of Nonalcoholic Steatohepatitis: NOT a Trivial Pursuit

369

Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate

370

Communication Strategies With Caregivers Following the Diagnosis of Rett Syndrome

371

2023 Rett Syndrome Year in Review: Expert Discussion on What's New

372

Keeping It Current: Latest European Updates in Prostate and Bladder Cancer

373

Strategies for Improving Patient Outcomes in Pediatric-Onset Seizures

374

Immunotherapy in Special Populations With Non-Small Cell Lung Cancer: What Would the Oncologist Do?

375

Navigating the Patient Journey for LA SCCHN: A Look at Treatments for Today and Tomorrow

376

Accessible Fertility Care: Breaking the Silence on Infertility

377

Biologic Treatment Selection for Psoriatic Disease in a Complex Treatment Landscape

378

Hidden in Plain Sight: Anticholinergic Burden in Patients With Overactive Bladder

379

Quickfire Updates From Brisbane: Expert Insights on the Latest Data and Implications for HIV Care

380

Practice Pearls for Managing Opioid-Induced Constipation

381

Cardiac MRI: Case Studies in Improving Patient Outcomes

382

To Know Is Better With Rapid Diagnostic Tests: Optimizing Respiratory Infection Management in Urgent Care

383

Great Debates in Primary Cardiovascular Prevention: Evaluating the Role of Aspirin

384

Improving Heart Failure Prognosis: Electronic Health Record Screening Tools to Detect Iron Deficiency

385

Psychiatry Mid-Year Review: Data Highlights on Antipsychotic Therapies

386

Clinical Consult in Nonalcoholic Steatohepatitis: Managing Intermediate- and High-Risk Patients

387

Clinical Pearls for Syndromic Testing: Closing the Loop on Acute Respiratory Infection Management

388

Expert Quickfire: Perspectives on the Burden and Prevention of Shingles

389

Hot Topics in Schizophrenia: Expert Poster Presentations From 2023 Psychiatry Congresses

390

Best Practices in the Identification and Management of Agitation Due to Alzheimer's Disease

391

Current Guidelines for Osteoarthritis: What Are the Practice Implications for Oral NSAIDs?

392

Taking Control of Fertility With Personalized Insights: Leveling the Fertility Care Continuum

393

The Patient's Journey With Type 1 Diabetes: From Screening to Diagnosis and Management

394

Raising the Bar: Optimizing Outcomes in Spondyloarthritis

395

Immunoglobulin A Nephropathy -- Targeting Gut Mucosal Immunity to Modify the Course of the Disease

396

Expert Insights Into the Biosafety of Oncolytic Immunotherapies and Their Combination With Immune Checkpoint Inhibitors

397

Deciphering Alzheimer's Disease Pathogenesis: From Signaling Pathways to Current Therapeutic Targets

398

A Detective Journey for Nephrologists: Practical Approaches to Differential Diagnosis of Rare Kidney Diseases

399

Ultrafast, Abbreviated, and Conventional Breast MRI: Who and Why?

400

Clinical Consult in Nonalcoholic Steatohepatitis: Are Your Patients at Risk?